Finance

Beta
Lists
DMAAU:NASDAQ
Drugs Made In America Acquisition Units
$10.71
0.00%
(0.00) 1D
May 28, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DMAAU...
Open
$10.99
High
$10.99
Low
$10.71
Mkt. cap
257.58M
Avg. vol.
921.00
Volume
95.00
52-wk high
$12.50
52-wk low
$10.29
Shares outstanding
23.03M
Open
$10.99
High
$10.99
Low
$10.71
Mkt. cap
257.58M
Avg. vol.
921.00
Volume
95.00
52-wk high
$12.50
52-wk low
$10.29
Shares outstanding
23.03M
News stories
From sources across the web
About Drugs Made In America Acquisition Units
CEO-
Employees-
Founded2024
Headquarters-
SectorCapital market
Websitedmaacorp.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
131.92K
263.70K
2.09M
143.30K
Operating expense
131.92K
263.70K
2.09M
143.30K
Total operating expenses
131.92K
263.70K
2.09M
143.30K
Operating income
-131.92K
-263.70K
-2.09M
-143.30K
Other non operating income
-
-
-
-
EBT including unusual items
2.29M
2.18M
212.96K
1.97M
EBT excluding unusual items
2.29M
2.18M
212.96K
1.97M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
2.29M
2.18M
212.96K
1.97M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
2.42M
2.45M
2.30M
2.11M
Interest expense
-
-
-
-
Net interest expenses
2.42M
2.45M
2.30M
2.11M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer